computer-assisted curve-fitting program graphpad prism version 3.0 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
computer-assisted curve-fitting program graphpad prism version 3.0
Computer Assisted Curve Fitting Program Graphpad Prism Version 3.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-assisted+curve-fitting+program+graphpad+prism+version+3%2E0/computer+assisted+curve+fitting+program+graphpad+prism+version+3+0/pm16289482-359-1-4
Average 90 stars, based on 1 article reviews
Computer Assisted Curve Fitting Program Graphpad Prism Version 3.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-assisted+curve-fitting+program+graphpad+prism+version+3%2E0/computer+assisted+curve+fitting+program+graphpad+prism+version+3+0/pm16289482-359-1-4
Average 90 stars, based on 1 article reviews
computer-assisted curve-fitting program graphpad prism version 3.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: First no-carrier-added radioselenation of an adenosine-A1 receptor ligand Article Snippet: The precursor synthesis and the no-carrier-added (n.c.a.) radiosynthesis of the adenosine-A1 receptor ligand 5 0-(methyl[Se]seleno)-N-cyclopentyladenosine ([Se]1) are described in this report.. A method was developed starting from elemental n.c.a. selenium-75, followed by a three-step polymer-supported radioselenation and deprotection which gave the radioligand with a radiochemical yield of 30%, a radiochemical purity of >99% and a specific radioactivity of >300GBq/mmol (8Ci/ mmol).. Preparation time was 40min. Article Title: Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): a potent and selective A(1)-adenosine receptor antagonist for in vivo imaging. Article Snippet: This report describes the precursor synthesis and the no-carrier-added (nca) radiosynthesis of the new A1 adenosine receptor (A1AR) antagonist [18F]8-cyclopentyl-3-(3-fluoropropyl)-1propylxanthine (CPFPX), 3*, with fluorine-18 (half-life ) 109.6 min).. Nucleophilic radiofluorination of the precursor tosylate 8-cyclopentyl-3-(3-tosyloxypropyl)-7-pivaloyloxymethyl1-propylxanthine, 2, with nca [18F]KF under aminopolyether-mediated conditions (Kryptofix 2.2.2/K2CO3) followed by deprotection was straightforward and, after formulation, gave the radioligand ready for injection with a radiochemical yield of 45 ( 7%, a radiochemical purity of >98% and a specific radioactivity of >270 GBq/μmol (>7.2 Ci/μmol).. Preparation time averaged 55 min. Article Title: Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethylamino-oxazolo[5,4-d]pyrimidines as potential A2A adenosine receptor antagonists for positron emission tomography (PET). Article Snippet: The brain A2A adenosine receptor (A2AAR) participates with the dopamine D2 receptor in the control of movement and also might influence behavior.. Because PET is an important tool for studying the roles of receptors in disease, a ligand for imaging the brain A2AAR is desirable.. This report describes the synthesis and A2AAR antagonist activities of a panel of phenyl-substituted 7-amino-2-(2-furyl)-5-phenylethylamino-oxazolo [5,4-d]pyrimidines, 11aa–af, and their 3-furyl congeners, 11ba–bd. |